A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC – James) has identified a protein within certain immune cells that is required for optimal immune responses to cancer. The findings, reported in the journal Science Advances, also suggest that the protein might be useful for predicting which cancer patients are less likely to respond to the form of therapy called immune checkpoint blockade.
- UMD-led study shows fear and anxiety share same bases in brain
- Patients who had more severe covid-19 may be the best donors for convalescent plasma therapy
- Astrophysics team lights the way for more accurate model of the universe
- Tropical cyclones moving faster in recent decades
- Untreated sleep apnea is associated with flu hospitalization